| dc.contributor.author | Velasco Criado, Ana Purificación | |
| dc.contributor.author | Hijazi Vega, Maruan | |
| dc.date.accessioned | 2024-01-31T12:22:22Z | |
| dc.date.available | 2024-01-31T12:22:22Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Velasco, A., & Hijazi, M. (2016). Oleic acid and cholinergic dysfunction in Down Syndrome models of the central nervous system. Journal of Neurology & Neuromedicine, 1(3). https://doi.org/10.29245/2572.942X/2016/3.1029 | es_ES |
| dc.identifier.issn | 2572-942X | |
| dc.identifier.uri | http://hdl.handle.net/10366/155097 | |
| dc.description.abstract | [EN]Down syndrome (DS): or trisomy 21: is the most common autosomal aneuploidy
and the leading genetic cause of intellectual disability. It is widely established
that mental retardation is primarily a consequence of brain functioning and
developmental abnormalities in neurogenesis. Some changes in the physical
structure of the dendrites are a major cause of impaired synaptic plasticity
of DS. The overexpression of the dual specificyty tyrsone phosphorylationregulated kinase 1A (DYRK1A): located on chromosome 21: is involved in
cellular plasticity and responsible for central nervous system disturbance in DS.
Oleic acid is a neurotrophic factor that promotes neuronal differentiation and
increases the levels of choline acetyltransferase (ChAT). Furthermore: it has
recently been shown that it induces migration and formation of new synapses
in euploid cells. However: remarkably oleic acid fails to reproduce the same
effects in trisomic cells.
Here we review the hypothesis that oleic acid-dependent synaptic plasticity
may be dependent on the lipid environment. Thus: differences in membrane
composition may be essential to understand why oleic acid promotes higher
cell plasticity in euploid than in trisomic cells. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.subject | Down syndrome | es_ES |
| dc.subject.mesh | Down Syndrome | * |
| dc.title | Oleic acid and cholinergic dysfunction in Down syndrome models of the central nervous system | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.29245/2572.942X/2016/3.1029 | es_ES |
| dc.identifier.doi | 10.29245/2572.942X/2016/3.1029 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |
| dc.journal.title | Journal of Neurology and Neuromedicine | es_ES |
| dc.volume.number | 1 | es_ES |
| dc.issue.number | 23 | es_ES |
| dc.page.initial | 1 | es_ES |
| dc.page.final | 5 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | síndrome de Down | * |